Literature DB >> 20697199

Nutrient sensing and insulin signaling in neuropeptide-expressing immortalized, hypothalamic neurons: A cellular model of insulin resistance.

Laura J Fick1, Denise D Belsham.   

Abstract

Obesity and type 2 diabetes mellitus represent a significant global health crisis. These two interrelated diseases are typified by perturbed insulin signaling in the hypothalamus. Using novel hypothalamic cell lines, we have begun to elucidate the molecular and intracellular mechanisms involved in the hypothalamic control of energy homeostasis and insulin resistance. In this review, we present evidence of insulin and glucose signaling pathways that lead to changes in neuropeptide gene expression. We have identified some of the molecular mechanisms involved in the control of de novo hypothalamic insulin mRNA expression. And finally, we have defined key mechanisms involved in the etiology of cellular insulin resistance in hypothalamic neurons that may play a fundamental role in cases of high levels of insulin or saturated fatty acids, often linked to the exacerbation of obesity and diabetes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697199     DOI: 10.4161/cc.9.16.12552

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  11 in total

1.  A novel missense mutation in the signal peptide of the human POMC gene: a possible additional link between early-onset type 2 diabetes and obesity.

Authors:  Monica Mencarelli; Alessandra Zulian; Raffaella Cancello; Luisella Alberti; Luisa Gilardini; Anna Maria Di Blasio; Cecilia Invitti
Journal:  Eur J Hum Genet       Date:  2012-05-30       Impact factor: 4.246

Review 2.  Food for thought: hormonal, experiential, and neural influences on feeding and obesity.

Authors:  Ilia N Karatsoreos; Joshua P Thaler; Stephanie L Borgland; Frances A Champagne; Yasmin L Hurd; Matthew N Hill
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

3.  Identification of novel genetic variants for type 2 diabetes, childhood obesity, and their pleiotropic loci.

Authors:  Chun-Ping Zeng; Xu Lin; Cheng Peng; Lin Zhou; Hui-Min You; Jie Shen; Hong-Wen Deng
Journal:  J Hum Genet       Date:  2019-02-28       Impact factor: 3.172

4.  Duodenal-jejunal bypass surgery up-regulates the expression of the hepatic insulin signaling proteins and the key regulatory enzymes of intestinal gluconeogenesis in diabetic Goto-Kakizaki rats.

Authors:  Dong Sun; Kexin Wang; Zhibo Yan; Guangyong Zhang; Shaozhuang Liu; Fengjun Liu; Chunxiao Hu; Sanyuan Hu
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

Review 5.  Inflammatory cause of metabolic syndrome via brain stress and NF-κB.

Authors:  Dongsheng Cai; Tiewen Liu
Journal:  Aging (Albany NY)       Date:  2012-02       Impact factor: 5.682

6.  Insulin suppresses ghrelin-induced calcium signaling in neuropeptide Y neurons of the hypothalamic arcuate nucleus.

Authors:  Yuko Maejima; Daisuke Kohno; Yusaku Iwasaki; Toshihiko Yada
Journal:  Aging (Albany NY)       Date:  2011-11       Impact factor: 5.682

Review 7.  Nutrigenetics and nutrigenomics insights into diabetes etiopathogenesis.

Authors:  Genoveva Berná; María Jesús Oliveras-López; Enrique Jurado-Ruíz; Juan Tejedo; Francisco Bedoya; Bernat Soria; Franz Martín
Journal:  Nutrients       Date:  2014-11-21       Impact factor: 5.717

8.  Alteration of NPY in hypothalamus and its correlation with leptin and ghrelin during the development of T2DM in a rat model.

Authors:  Qing-Jiu Zhang; Chang-Chun Yang; Song-Yun Zhang; Li-Hui Zhang; Jie Li
Journal:  Springerplus       Date:  2016-11-03

Review 9.  Cellular Stresses and Stress Responses in the Pathogenesis of Insulin Resistance.

Authors:  Arnold N Onyango
Journal:  Oxid Med Cell Longev       Date:  2018-07-09       Impact factor: 6.543

Review 10.  Type 2 Diabetes-Associated Genetic Polymorphisms as Potential Disease Predictors.

Authors:  Beska Z Witka; Dede J Oktaviani; Marcellino Marcellino; Melisa I Barliana; Rizky Abdulah
Journal:  Diabetes Metab Syndr Obes       Date:  2019-12-18       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.